Cancer Treatment Facilities Market Size & Share 2025 – 2034

Cancer Treatment Facilities Market Size

The global cancer treatment facilities market was valued at around USD 49.8 billion in 2024 and is estimated to grow at 7.6% CAGR from 2025 to 2034. Cancer treatment facilities are specialized health care centers which are engaged in the diagnosis, treatment, and management of various types of cancer.

Such facilities provide services such as surgery, chemotherapy, radiation therapy, immunotherapy as well as follow-up care. They often employ a blended multidisciplinary group that includes oncologists, radiologists, surgeons, and nursing staff to provide tailored therapy.
 

The worldwide rising prevalence of cancer is the foremost factor impacting the market for cancer treatment facilities. Around 20 million new cases of cancer, excluding nonmelanoma skin cancers, were diagnosed in the world in the year 2022. This projection is expected to drastically increase to 35 million by the year 2050, mostly due to population surge and increased life expectancy. Furthermore, cancer mortality reached 9.7 million deaths in the year 2022, averaging 26,700 deaths per day which depicts a severe infrastructural requirement in oncology and advanced treatment options. Thus, as a result of these factors the market is expected to grow steeply in the upcoming years.
 

In addition, the global increase in the elderly population is one of the main reasons the surge in the market for cancer treatment facilities because older adults are more susceptible to diseases, they have a higher likelihood of being diagnosed with cancer. According to the data of the UN, the world population aged 65 and over is forecasted to increase from 761 million in 2021 to 1.6 billion by 2050.
 

This shift in demographics will greatly impact the availability of cancer-related healthcare services, because aging hugely contributes to the risk of developing cancer. For this reason, cancer treatment facilities are improving their infrastructure and adopting state-of-the-art technologies such as precision oncology and multidisciplinary care models. Such changes aim to provide sustained treatment designed for managing the particular needs of the growing elderly population, thereby fueling market expansion.
 

Cancer Treatment Facilities Market Trends

• To enhance patient comfort and compliance, cancer treatment facilities are incorporating non-invasive methods of diagnostics. For example, Apollomedics Hospital in Lucknow introduced 'Colofit’, a colorectal cancer screening initiative using the FIT, Fecal Immunochemical Test, in May 2025. This test is a straightforward and reliable diagnostic method which assesses hidden blood in stool samples with minimal discomfort to the patient.
   
• Further, the governments of nations around the world are taking steps to raise the level of cancer awareness and its early diagnosis. For example, in India, the government of Tamil Nadu initiated a door to door cancer screening campaign in Coimbatore City for the early identification of oral, breast and cervical cancers in May 2025. These initiatives are aimed at enhancing diagnostic initiation and treatment results.
   
• In addition, medical tourism is radically transforming cancer treatment facilities, specifically in countries where oncology services are offered at lower prices. India is an example of a country with a pronounced and growing medical tourism, welcoming foreign patients for all kinds of treatments, which includes cancer therapies. The medical facilities are of good quality and the costa are favorable for foreign patients.
   

Cancer Treatment Facilities Market Analysis

In 2021, the global market was valued at USD 41.6 billion. The following year, it saw a slight increase to USD 44.1 billion, and by 2024, the market further climbed to USD 49.8 billion. Based on type, the global market is segmented into cancer surgery, chemotherapy, radiation therapy, immunotherapy, bone marrow transplantation, and other treatment types. The cancer surgery segment accounted for the highest market share of 32.3% in 2024.
 

• Surgical intervention is the primary treatment method for most solid tumors, especially in early-stage breast, colorectal, and lung cancers. The segment's dominance continues to provide clinical efficacy and an increase in procedural volume from the rising incidence of cancer.
   
• For example, GLOBOCAN estimates suggest that more than 24 million new cancer cases will be diagnosed globally by 2030 and out of these, 17 million patients are expected to have surgery, with many of them requiring multiple surgeries. Secondary studies independently estimating the data suggest that this will lead to approximately 45 million cancer-related surgeries. Moreover, the demand for cancer surgeries is anticipated to increase by 52% from 2018 to 2040, which is 5 million extra surgical procedures by 2040. Such figures contribute in the expansion of this market in the near future.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on cancer type, the cancer treatment facilities market is segmented into blood cancer, breast cancer, prostate cancer, gastrointestinal cancer, colorectal cancer, lung cancer, and other cancer types. Blood cancer segment dominated the market with the largest revenue share of 26.1% in 2024.
 

• The expansion is fueled by the consistent clinical need and high coverage for the specialized treatment infrastructure for operational facilities and specialized infrastructure for treating hematological tumors.
   
• According to the data stated by the Leukemia and Lymphoma Society, a person in the U.S. is diagnosed with leukemia, lymphoma, or myeloma about every three minutes. Lymphomas accounted for approximately 187,740 new cases of these cancers in 2024. The multifaceted, expensive, and often aggressive treatment regimens including chemotherapy, bone marrow transplantation, and even immunotherapy are dominantly fueling growth.
   
• In addition, the need for follow up care which is long-term, multidisciplinary clinical teams, and provision of advanced diagnosis further strengthens the necessity for these operational facilities over other cancers.
   

Based on providers, the cancer treatment facilities market is segmented into hospitals and cancer centers. Hospitals dominated the market with the largest revenue share of 67.5% in 2024 and is anticipated to witness growth at a CAGR of 7.5%.
 

• The rising prevalence of cancer and the sophisticated tools for its detection, as well as the availability of multidisciplinary medical teams and surgeons in the hospitals, has been responsible for their dominant share.
   
• Patients prefer hospitals because they have all the necessary therapy options ranging from chemotherapy to hormone therapy and radiotherapy.
   
• For example, Fortis Healthcare announced in March 2024 regarding their plan to invest in MR LINAC and Gamma Knife technologies which will enhance the capabilities of their oncology facilities. These expenditures are going to improve the available infrastructure and significantly increase their bed capacity in several of their North India locations.
   

The North America cancer treatment facilities market held a significant share in the global market with a market share of 32.9% in 2024. The market is driven by high cancer prevalence, well-established healthcare infrastructure, high healthcare expenditure, and early adoption of advanced treatment modalities such as immunotherapy and robotic surgery.
 

The U.S. market was valued at USD 12.5 billion and USD 13.3 billion in 2021 and 2022, respectively. The market size reached USD 14.9 billion in 2024, growing from USD 14.1 billion in 2023.
 

• The market for cancer treatment facilities in the U.S. is anticipated to grow further as the population ages and cancer cases increase. According to the Census Bureau, people aged 65 and older will increase from 58 million in 2022 to 82 million by 2050, a 47% increase. Based on the Global Cancer Observatory, the U.S. had 89.1% of new cancer cases in North America in 2022.
   
• This encourages the development of integrated cancer centers that provide robotic surgery, immunotherapy, and precision medicine. Leading providers such as HCA Healthcare are growing through partnerships and AI adoption. Further growth is supported by value-based care models and federal initiatives focused on cancer.
   

Europe cancer treatment facilities market accounted for USD 10.1 billion in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The market in Europe is also expanding due to an aging population and increasing cases of cancer. The European Commission reported that 21.1% of the EU population was 65 years of age or older in 2022 and is expected to reach 32.5% by 2100. This increases the demand for oncology services. There is a widening scope for both public and private healthcare providers in areas such as surgical oncology, radiotherapy, which is expected to reach USD 11.4 billion by 2032, and precision medicine.
   
• The infrastructure and oncology services offered in Germany, France, and Italy place them as leaders in cancer care; moreover, cross-border collaborations and EU-funded programs foster innovation and accessibility. The market is further evolving with a shift to outpatient care, remote oncology consultations, telehealth services, and collaborative treatment frameworks.
   

Germany cancer treatment facilities market is anticipated to witness considerable growth over the analysis period.
 

• Germany held a prominent position in the European market for cancer treatment facilities due to the high burden of diseases, well-established healthcare systems, and the growing elderly population.
   
• The incidence rate of breast cancer in 2022 was 148 per 100,000 women, making it the most common cancer among women. For males, trachea, bronchus, and lung cancers were the most prevalent at an incidence rate of 84.9 per 100,000.
   
• Alongside having advanced hospital infrastructure, extensive insurance coverage, and public funding which ensures modernization of cancer research and treatment, Germany strengthens its position as a regional leader in oncology care.
   

The Asia Pacific cancer treatment facilities market is anticipated to grow at the highest CAGR of 8% during the analysis timeframe.
 

• The surge of emerging oncology service markets is being driven by the increasing prevalence of cancer, construction of new healthcare facilities, and greater investments in oncology services.
   
• Supported by favorable political environments and healthcare reforms, countries such as China, India, and South Korea are quick to adopt advanced treatment technologies, including radiotherapy, immunotherapy, and robotic surgeries.
   
• Further, coupled with increased insurance access, government-funded cancer screening, and medical tourism, there is a growing demand for specialized multidisciplinary oncology treatment centers.
   

China cancer treatment facilities market is predicted to grow significantly over the forecast period.
 

• China is one of the most important contributors to the Asia Pacific market due to its exceptionally high healthcare burden, healthcare capacity, and cancer prevalence. According to GLOBOCAN 2022, China had 4.8 million new cancer cases which is 24 percent of the world's total.
•  
• Moreover, the developing oncology infrastructure of the country is enhanced by national policy frameworks like Healthy China 2030 and increasing public and private sector collaboration.
   
• Additionally, enhanced investment in AI diagnostics, digital health, proton therapy centers, and other facilities are further expanding the market.
   

Brazil is experiencing significant growth in cancer treatment facilities market, driven by its expanding adoption of chronic disease management.
 

• According to GLOBOCAN 2022, Brazil recorded 627,193 new cancer cases and 278,835 related deaths, reflecting a significant demand for timely diagnostics and advanced therapeutic care.
   
• Further, government-led investments in public oncology networks and expansion of private multispecialty hospitals are further accelerating market development.
   

Saudi Arabia cancer treatment facilities market is poised to witness substantial growth in Middle East and Africa market during the forecast period.
 

• Saudi Arabia’s aging population is rising rapidly, with those 60 years or older increasing 5-fold from 2 million in the year 2020 i.e., 5.9% of the total population of the country to 10.5 million by 2050.
   
• Thus, a large portion of the population is at high risk of cancer, which necessitates cancer treatment infrastructure in the country, further fostering market growth.
   

Cancer Treatment Facilities Market Share

The market is moderately consolidated, with key players including both regional and multinational hospital networks. The top four players—HCA Healthcare, GenesisCare, Tenet Healthcare, and Apollo Hospitals Enterprise—together account for approximately 40% of the global market share. These organizations leverage economies of scale, multidisciplinary cancer centers, and investments in advanced modalities such as precision oncology, proton therapy, and AI-driven diagnostics.
 

Growth strategies include geographic expansion, partnerships with life sciences companies, and integration of outpatient oncology services. Other prominent players such as Fortis Healthcare, Ramsay Health Care, and American Oncology Institute strengthen competition through localized services and scalable cancer care delivery models.
 

Cancer Treatment Facilities Market Companies

Some of the eminent market participants operating in the cancer treatment facilities industry include:

• Alliance HealthCare Services
• American Oncology Institute
• Apollo Hospitals Enterprise
• Cancer Treatment Centers of America
• Compass Oncology
• Curie Oncology
• Fortis Healthcare
• GenesisCare
• HCA Healthcare
• Healthcare Global Enterprises
• IHH Healthcare Berhad
• Narayana Hrudayalaya
• OncoLife Hospitals
• Ramsay Health Care
• Tenet Healthcare
   
• Healthcare has integrated cancer centers with a network of hospitals enabling all-in-one diagnosis and treatment pathways. The company implements advanced radiation therapy facilities and surgical oncology infrastructure in both urban and suburban centers.
   
• HealthCare Global Enterprises (HCG) operates specialized cancer hospitals in India and Africa. It offers imaging, diagnostics, and treatment in one location for enhanced patient convenience and further focuses on clinical protocols, microbiome-driven therapies, and digital health for improved efficacy.
   

Cancer Treatment Facilities Industry News:

• In April 2024, President of India Droupadi Murmu inaugurated India’s first home-grown CAR T-cell therapy cancer treatment. Harnessing significant advances from IIT Bombay and Tata Memorial Centre, NexCAR19 therapy is expected to bring forth a revolutionary shift in offering affordable care.
   
• In March 2024, City of Hope (parent organization of Cancer Treatment Centers of America) initiated their Cell Therapy and Blood and Marrow Transplantation Programs at the City of Hope Cancer Center Atlanta.
   
• In January 2024, Apollo Cancer Centers announced the launch of India’s first AI-precision oncology Centre. It is expected to assist oncologists along with patients and caregivers in achieving favorable outcomes in a timely manner using AI.
   

The cancer treatment facilities market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Treatment Type

• Cancer surgery
• Chemotherapy
• Radiation therapy
• Immunotherapy
• Bone marrow transplantation
• Other treatment types

Market, By Cancer Type

• Blood cancer
• Breast cancer
• Prostate cancer
• Gastrointestinal cancer
• Colorectal cancer
• Lung cancer
• Other cancer types

Market, By Provider

• Hospitals
• Cancer centers

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE